While hyperinsulinemia has been generally attributed to β-cell hypersecretion of insulin, it is not clear whether it is a primary event governed either by central neural or β-cell intrinsic regulation, or by a secondary event arising from an adaptive response to diminished peripheral insulin sensitivity in the dysmetabolic state[25]. The gene discussed is INS; the disease is hyperinsulinism.